Metformin in Breast Cancer: Molecular Mechanisms, Preclinical Evidence and Clinical Implications

Background: Metformin, a first-line therapy for type 2 diabetes mellitus, has recently attracted attention for its potential anticancer properties. Preclinical and clinical evidence suggests that it modulates cancer cell metabolism, proliferation and survival pathways, indicating its possible role...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ewelina Nowicka, Izabela Brynczka, Klaudia Martyna Patrzykąt, Zofia Gorzoch-Burduk, Julia Puzio, Paula Marcinkowska, Marta Krzyżaniak, Michał Jezierski, Kinga Popielarska, Kamila Wróblewska
Format:	Artigo
Idioma:	Inglês
Publicat:	Kazimierz Wielki University 2025-12-01
Col·lecció:	Journal of Education, Health and Sport
Matèries:	metformin breast cancer AMPK mTOR cancer therapy chemotherapy
Accés en línia:	https://apcz.umk.pl/JEHS/article/view/66918
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!